Human chromosomes 6 and 21 are both necessary to confer sensitivity to human Interferon y (Hu-IFN-y),
specifi factor(s) and can substitute for human chromosome 21 to reconsitute the Hu-IFN-y-receptor-mediated induction of class I HLA antigens. However, the factor encoded on the yeast articial chromosome does not confer antiviral protection aainst encephalomyocarditis virus, demonstrating that an additional factor encoded on human chromosome 21 is required for the antivral activity.
Human interferon y (Hu-IFN-y) is a protein that induces a variety of biological responses such as antiviral, antiproliferative, and immunomodulatory activities in sensitive ceils (1) (2) (3) (4) (5) . Immunoregulatory functions induced by Hu-IFN-y, such as induction ofclass I and class II human HLA antigens, activation of macrophages, regulation of immunoglobulin class switching, and up-regulation of Fc receptor expression are involved in modulating a variety of other host defense mechanisms (5) (6) (7) (8) (9) (10) . The first event in inducing these responses is the specific binding of IFN-y to its cell-surface receptor encoded on human chromosome 6 (11) or mouse chromosome 10 (12) . Human chromosome 6 also encodes the human class I major histocompatibility complex (MHC) antigens (13) . However, human chromosomes 6 and 21 (14, 15) and mouse chromosomes 10 and 16 (16) are required for sensitivity to IFN-y, as measured by the induction of class I MHC antigens, which indicates that the binding of IFN-y to the receptor is not sufficient to induce these antigens. Interaction between the extracellular domain of the Hu-IFN-y receptor and the species-specific factors that leads to class I HLA antigen induction upon treatment with Hu-IFN-,y was
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suggested by experiments with chimeric receptors (17) (18) (19) . Furthermore, a 5-amino acid sequence (YDKPH) of the intracellular domain of the Hu-IFN-y receptor is required for this activity (20, 21) . Moreover different accessory factors are involved in encephalomyocarditis virus (EMCV) and vesicular stomatitis virus antiviral activity (20) . However, little is known about how the binding of Hu-IFN--y to its receptor initiates this diverse array of functional changes.
The region of chromosome 21 necessary for sensitivity to Hu-IFN-y, as assayed by the expression of class I HLA antigens, was further localized within a region of 41-3 Mb of chromosome 21q with irradiation-reduced somatic hybrid cells (22) . The cloned Hu-IFN-y-receptor cDNA (23, 24) was expressed in hybrid cells that have human chromosome 21q as the sole human chromosome to reconstitute a biologically active Hu-IFN-y receptor for HLA class I antigen induction (25) and EMCV antiviral protection activity (20) . Thus, human chromosome 21q appeared to encode all necessary factors for both activities. Also a recent study with mousehuman hybrid cells transfected with the Hu-IFN-y receptor cDNA showed that human chromosome 21 is sufficient for induction of class I MHC antigens, EMCV antiviral activity, and induction of 2',5'-A oligoadenylate synthetase in response to Hu-IFN-y (26) .
The cloning of DNA into yeast artificial chromosomes (YACs) has allowed isolation of much larger DNA fiagments than was previously possible (27) . Also, development of PCR-based YAC screening methods has facilitated the identification of specific YAC clones (28) . These large cloned segments have potential applications for the isolation of functional domains from chromosomes (29 Proc. Natl. Acad. Sci. USA 90 (1993) fused to hamster cells containing human chromosome 6q and the human HLA-B7 gene (14, 15) (37) . Each of the YAC clones containing the neomycin-resistance (neor) gene was fused to 16-9 cells as described (33) . Thirty-six hours later, plates were washed with phosphate-buffered saline to remove dead cells and yeast, then refed with complete F-12 medium containing G418 at 450 ug/ml (GIBCO). Cells were fed as necessary, and resistant colonies typically appeared after [10] [11] [12] [13] [14] days. The G418-resistant colonies were pooled and expanded for further analysis.
Electrophoresis, Hybridization Procedures, and Assays. Agarose plugs were prepared as reported (38) . The agarose plugs were analyzed by pulsed-field gel electrophoresis (PFGE) (CHEF, OWL Scientific Plastics, Cambridge, MA). The DNAs were blotted onto Nytran (Schleicher & Schuell) by standard Southern blot procedures (24, 25) . DNA probes were labeled with [a-32P]dCTP (NEN, 3000 Ci/mmol; 1 Ci = 37 GBq) with random hexadeoxynucleotides as primers (39) . Cytofluorographic analysis of cells for expression of the HLA-B7 surface antigen was done as described (15, 25) , except that antibiotic G418 was omitted because it was found that its presence inhibited MHC induction (T.M.M., unpublished observation). Transfected cells were assayed for resistance to EMCV by a cytopathic-effect inhibition assay (40) . RESULTS 3xlS Region YACs. The 3xlS somatic cell hybrid contains DNA that encodes one component of the human type I IFN receptor (22, (41) (42) (43) as well as the accessory factors responsible for class I HLA antigen induction upon binding of Hu-IFN-y to its receptor (14, 15, 22, 44) . The segment of human chromosome 21 in 3xlS cells is referred to as the 3xlS region, which is =1-3 Mb in size, depending on the estimation method (ref. 44 ; R.J.D., unpublished data). To identify the gene(s) for accessory factor(s) for the Hu-IFN-y receptor system, Jung (44) prepared a cosmid library from 3xlS DNA and screened the library with labeled total human DNA so that cosmid clones containing highly repetitive human sequences (Alu, Kpn, etc.) could be selected. More than 200 cosmid clones were isolated, which theoretically covered the 3xlS region two to six times. The resultant cosmids were transfected into CHO cells that had been stably transfected with both the HLA-B7 gene and Hu-IFN-y-receptor cDNA in an attempt to reconstitute a biologically active Hu-IFN-yreceptor system capable of inducing human class I HLA antigen expression. This approach was not successful, possibly because this region may contain several genes necessary for activity that cannot be cloned into a single cosmid, the gene is too large to be accommodated in a single cosmid vector, or there was a bias during screening with human repetitive DNA so that the particular region of DNA was not represented in the cosmid clones positive for human DNA. For these reasons, we chose to use YAC clones to carry out a similar experiment to that described above because YAC clones can maintain >1 Mb of DNA as an exogenous fragment (27, 45) . Through the Chromosome 21 Joint YAC Screening Effort, we obtained 10 YAC clones screened with various primer pairs derived from six different loci that are scattered in the vicinity of the 3xlS region as shown in Fig.  1 and Table 1 . The superoxide dismutase (D21SODI), D21S58, GART (D21PRGS), D21S65, H8 (D21517), and IFNAR (D21IFNAR) loci were known to be in the 3xlS region (22) . Although the D21S55 locus was not in the 3xlS region, it was close enough to the 3xlS region to be tested. The (Fig. 2A) . About 76% of the neor-positive clones were targeted to the YAC rather than yeast chromosome II, which contains a mutated LYS2 gene (data not shown). Because the LYS2 gene in S. cerevisiae AB1380 is almost intact, it is possible that the LYS2 gene in the integrating plasmid was targeted to the endogenous yeast LYS2 sequence in some cases. We note that the GART D142H8.neo.18 clone had a smaller YAC than the original one ( Fig. 2A) . In this case, it is possible that two distant Alu sequences were targeted, and the internal DNA fragments between them were lost during recombination (46) . To test whether the neor gene cassette is integrated into the YAC intact, total yeast chromosomal DNA from targeted YAC clones were digested with BamHI and Xho I, and the blot was probed with labeled neor gene. As shown in Fig. 2B (Table 1) . Not all fusions generated G418-resistant colonies, possibly due to disruption of the neor gene during the targeting process. Colonies from the individual fusions were pooled and analyzed for IFNdependent class I HLA antigen induction by cytofluorography. The parental 16-9 cells displayed very good class I HLA induction upon treatment with Hu-IFN-aA/D, a human IFN active on hamster cells (47) (Fig. 3A) , and a slight reduction in HLA expression in response to Hu-IFN-y at 1000 units/ml (Fig. 3B) . The 16-9 cells transformed by fusion with GART D142H8.neo.18 (henceforth called YAC-JS2) also exhibited a good response to Hu-IFN-aA/D (Fig. 3C) . In addition, they also showed good HLA induction upon treatment with Hu-IFN-y at 1000 units/ml (Fig. 3D) . Treatment of these transformed 16-9 cells with Hu-IFN-y at 200 units/ml also gave a response similar to that for treatment with 1000 units/ml (data not shown). The results shown in Fig. 3 with 16-9 cells fused to YAC-JS2 were performed on several occasions with pools of clones and with individual clones with similar results. It is interesting to note that a colony derived from the GART 142H8.neo.16 YAC was negative for HLA induction by Hu-IFN-y. This YAC clone may have a deletion of -10 kb because the apparent YAC size is similar to the original GART YAC, even after integration ofthe 10-kb plasmid (Fig. 2A, lane  2) . It is difficult to conclude definitively that the negative response resulted from the deletion of a portion of the gene(s) that encodes the Hu-IFN-y accessory factor(s) because only one colony, which may not have incorporated the entire YAC (31), was assayed. However, if we screen a sufficient number of neor-positive YACs that do not respond to Hu-IFN-y, we may be able to identify the gene(s) disrupted during integration of the pJS1 plasmid. Antiviral Activity of 16-9 Cells Transformed with YAC-JS2.
It was reported that hamster-human somatic hybrid 153B7-8 cells (carrying chromosome 21q as its sole human chromosome) transfected with the Hu-IFN-y-receptor cDNA are protected against EMCV infection and display an increase in class I HLA antigen expression upon treatment with Hu-IFN-y (20, 25) . Furthermore, because the 3xlS region of chromosome 21q is sufficient to complement the Hu-IFN-y receptor for class I HLA induction (22, 44) , we tested whether this region also encodes the accessory factor that confers protection against EMCV infection in response to Hu-IFN-y. The results indicate that the 3xlS region of chromosome 21q encodes the accessory factors for EMCV antiviral protection (Table 2 ). However, 16-9 cells transformed with YAC-JS2 (expressing the accessory factors for class I HLA antigen induction) do not show any protection against EMCV. This result indicates that there are at least two accessory factors on human chromosome 21q: one is required for induction of MHC class I antigens, and a second is required for protection against EMCV.
DISCUSSION
Although expression of proteins has been demonstrated with YACs containing known genes (30) (31) (32) , this study demonstrates a specific biological function from an undefined gene in a YAC expressed in eukaryotic cells. To introduce the G418 antibiotic-resistance gene into the YACs used in this study, an integrating plasmid (pJS1) was constructed for S. cerevisiae strain AB1380 that has been widely used for construction of YAC libraries. In conjunction with yeast and eukaryotic cell-fusion techniques, the integrating plasmid was used to introduce the neor gene into the YACs so that the functional activity of the YACs could be determined. Furthermore, the integrating plasmid can also be used to localize the region of the YAC responsible for functional activity through its ability to produce insertional inactivation of genes and deletions. Recombination with plasmid pJS1 can produce deletions of various size within a YAC. We have observed deletions of up to 350 kb for the GART D142H8 YAC.
Our study showed that the chromosome 21 accessory factor gene necessary for class I HLA antigen induction by Hu-IFN-'y is located in the 540 kb of human DNA in the GART D142H8 YAC. This observation is consistent with data that indicated that the gene for the accessory factor is located in the distal portion of band 21q22.1, near markers D215S8 and GART (21, 43) .
We previously demonstrated that the accessory factors required for vesicular stomatitus virus protection are different from those leading to EMCV protection after Hu-IFN-y treatment (20) . The observation that a small segnent of human chromosome 21q (3xlS region) was sufficient to induce class I HLA antigen expression and EMCV protection with Hu-IFN-y suggested that the same accessory factor was involved (20) . However, the observation that 16-9 cells transformed with YAC-JS2 were not protected against EMCV challenge is evidence that another accessory factor is necessary for this antiviral activity or that both the antiviral factor and the class I MHC induction factor are required for this antiviral activity. Thus, our data indicate that the distinct additional factor responsible for the EMCV antiviral effect present in the 3xlS region is not included in the GART D142H8 YAC. One might argue that the factor for antiviral activity is in the GART D142H8 YAC but the gene was disrupted due to targeting of the integration plasmid. However, because two separate pools of 16-9 cells fused with different neor genetargeted YACs (GARTD142H8.neo.3 and YAC-JS2; Table 1) showed MHC class I induction but no protection against EMCV when treated with Hu-IFN-y, the argument for disruption of the same gene is less convincing.
The identification of a YAC that encodes the speciesspecific accessory factor for class I HLA induction by Hu-IFN-y should eventually lead to identification ofthe cDNA for the protein. This information will help us to understand the interactions between the Hu-IFN-y receptor and the accessory factors. To locate the genes and to find cDNAs for the accessory factors, various approaches such as YAC fragmentation (46), exon-trapping (48) , hybrid selection of cDNA with the YAC (49) , and direct screening of the cDNA library with the YAC (50) can be done. We have mapped the GART D142H8 YAC with some restriction endonucleases (Not I and Asc I). The mapping data suggest that the GART D142H8 YAC is similar to yGART2 (600 kb) described by Gnirke et aL (32) because both YACs have two Not I sites and the GART gene is located between two Not I sites (170 kb). Our results are consistent with and extend the results of Chumakov et al. (51) , who reported a physical map of human chromosome 21 constructed with the use of overlapping YACs. Our current efforts are directed at defining the specific gene or genes on the GART D142H8.neo.18 YAC that contribute the chromosome 21 accessory function required for activity of the Hu-IFN-'y receptor. This study and our previous studies (20, 44) show that accessory factor functions for class I MHC induction, protection of cells against EMCV infection, and protection against vesicular stomatitis virus infection are mediated by different factors or a different combination of factors. We thus conclude that a family ofaccessory factors that mediate specific intracellular signals is associated with the IFN-y receptor.
